BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 2, 2026
Home » Topics » Conferences

Conferences
Conferences RSS Feed RSS

Brain cancer illustration
Cancer

Thorium-227-based radioimmunotherapy tested in preclinical studies for the treatment of glioblastoma

Oct. 21, 2022
Investigators have developed α-therapeutic thorium-227-labeled DUNP19 ([227Th]Th-DUNP19), an antibody-conjugated radiopharmaceutical with high specificity and affinity to LRRC15.
Read More
PET imaging
Diagnostics

Development of heterobivalent radiotracer targeting PSMA and GRPR

Oct. 21, 2022
Researchers have detailed the development and preclinical characterization of a novel heterobivalent radiotracer targeting prostate-specific membrane antigen (PSMA) and the gastrin-releasing peptide receptor (GRPR).
Read More
Attention deficit hyperactivity disorder brain connections illustration.
Neurology/Psychiatric

C2orf82 deletion tied to neurobehavioral impairment in mice

Oct. 20, 2022
C2orf82, also known as small novel rich in cartilage (SNORC), is a gene located on chromosome 2 that is known to play a role in chondrocyte maturation.
Read More
Diagnostics

68Ga-based radiotracer targeting LHRH as novel prostate cancer imaging agent

Oct. 20, 2022
Receptors for luteinizing hormone-releasing hormone (LHRH) are found on most prostate cancer (PC) cells...
Read More
Doctor shows patient anatomy image of prostate on computer.
Cancer

Preclinical characterization of the α-therapy 225Ac-pelgifatamab

Oct. 20, 2022
Bayer AG has reported the preclinical biodistribution and efficacy results on the development of 225Ac-pelgifatamab...
Read More
Cancer

PARP-targeting radiopharmaceutical for cancer treatment

Oct. 20, 2022
Researchers from the University of Oxford and University Medical Center Groningen...
Read More
Pipet, test tubes, chemical structure
Cancer

Preclinical studies on the theragnostic pair [203Pb/212Pb]PSC-PEG2-TOC

Oct. 20, 2022
Viewpoint Molecular Targeting LLC has reported its investigation...
Read More
Neurology/Psychiatric

T cells, not just brain cells, play role in MDD

Oct. 20, 2022
By Anette Breindl
At first blush, to say that depression occurs with other diseases may seem like belaboring the obvious. After all, to put it in the bluntest possible terms, it’s sad to be sick. But by looking more closely, it soon becomes clear that the association is stronger than that. The strongest association between depression and other diseases, Stefan Gold told the audience at the European College of Neuropsychopharmacology (ECNP) annual conference in Vienna this week, is “not necessarily the most severe or most immediately life-threatening disorders… [it’s] across the spectrum."
Read More
Brain and DNA
Biomarkers

Relationship found between CNR1 rs12720071 and environmental factors in development of psychosis

Oct. 19, 2022
The use of cannabis and childhood trauma have been proposed as environmental factors impacting the risk of psychosis. Recent findings have suggested a link between genetic variants in the cannabinoid receptor 1 gene (CNR1) and cannabis use with the risk of psychosis development.
Read More
Neurology/Psychiatric

FTY-720 prevents memory impairment in a murine model of Alzheimer’s disease

Oct. 19, 2022
The S1PR agonist FTY-720 (fingolimod)...
Read More
Previous 1 2 … 291 292 293 294 295 296 297 298 299 … 3205 3206 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • Liver over digital lens background

    EASL 2026: Emerging liver disease targets to watch

    BioWorld
    At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing